F&C Asset Management’s Pfizer PFE Stock Holding History

F&C Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$66.6M	Sell	2,185,256 -25,317	-1%	-$755K	0.84%	19
2013 Q4	$64.2M	Sell	2,210,573 -158,694	-7%	-$4.62M	0.78%	21
2013 Q3	$64.5M	Sell	2,369,267 -48,415	-2%	-$1.32M	0.84%	15
2013 Q2	$64.4M	Buy	+2,417,682	New	+$66.8M	0.88%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

F&C Asset Management's PFE Position: Q1 2014 in Review

F&C Asset Management reduced its Pfizer (PFE) stake by 1.1% in Q1 2014, selling an estimated $755K and leaving 2,185,256 shares worth $66.6M. The position accounts for 0.84% of the portfolio, ranked #19.

F&C Asset Management first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. 1,779 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

F&C Asset Management held 2,185,256 shares of Pfizer worth $66.6M as of Q1 2014.
F&C Asset Management sold 25,317 Pfizer shares in Q1 2014, an estimated $755K.
Pfizer made up 0.84% of F&C Asset Management's portfolio in Q1 2014, its #19 holding.
F&C Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
1,779 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.